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The European Society of Clinical Microbiology and Infectious Diseases
Study Group on Clostridium difficile (ESGCD)
The European Society of Clinical Microbiology and Infectious
Diseases Study Group on Clostridium difficile (ESGCD) was
established to act as a focus for research into Clostridium difficile
on a European-wide basis and, since its launch earlier this
year, over 50 workers from 15 different European countries
have joined the Study Group. Thanks to ESCMID support,
the first scientific meeting of ESGCD took place at the
11th ECCMID in Istanbul on 3 April 2001. The symposium
was entitled ‘Update on C. difficile infection’ and was well
attended, filling the allocated hall in the convention center.
Part of this issue is based on the proceedings of the symposium
at which invited speakers presented the latest information
on laboratory diagnosis, epidemiology, pathogenesis, typing
and mathematical modeling of C. difficile disease. General
interest in the topic at ECCMID was maintained, with a
good number of high quality posters on C. difficile in the
poster session. The symposium was followed by an ESGCD
business meeting at which officers of the Study Group were
elected. ESCMID members wishing to find out more about
the activities of ESGCD are encouraged to visit the ESCMID
web-site.
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